Invention Grant
- Patent Title: Fusion partner for production of monoclonal rabbit antibodies
-
Application No.: US13732912Application Date: 2013-01-02
-
Publication No.: US09328333B2Publication Date: 2016-05-03
- Inventor: Robert Pytela , Weimin Zhu , Yaohuang Ke , Qi Qian , Harry C. Au
- Applicant: EPITOMICS, Inc.
- Applicant Address: US CA Burlingame
- Assignee: EPITOMICS, Inc.
- Current Assignee: EPITOMICS, Inc.
- Current Assignee Address: US CA Burlingame
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Main IPC: C12P21/00
- IPC: C12P21/00 ; C12N5/16 ; C07K16/00

Abstract:
The invention provides a rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody. The immortal B-lymphocyte does not detectably express endogenous immunoglobulin heavy chain and may contain, in certain embodiments, an altered immunoglobulin heavy chain-encoding gene. A hybridoma resulting from fusion between the subject immortal B-lymphocyte and a rabbit antibody-producing cell is provided, as is a method of using that hybridoma to produce an antibody. The subject invention finds use in a variety of different diagnostic, therapeutic and research applications.
Public/Granted literature
- US20140004566A1 Fusion Partner for Production of Monoclonal Rabbit Antibodies Public/Granted day:2014-01-02
Information query